DANOS OLIVIER (Chief Scientific Officer) received a stock award from REGENXBIO INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 8/5/2024ACC: 0001562180-24-006013
Officer· Chief Scientific Officer
Since Oct 2018
+60.23K
Net shares
Net buyer
$13.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
60.23K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.36K
Price / share
$9.95
Trade value
$13.56K
% of position
1.1%
6/28/2024
124.85K→126.22K
Common Stock
Direct
Shares
+58.87K
Price / share
—
Trade value
—
% of position
46.6%
8/1/2024
126.22K→185.08K
Total
Net shares
+60.23K
Net value
$13.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/28/2024 | A · Award | +1.36K | $9.95 | $13.56K | 1.1% | 124.85K | 126.22K |
| Common Stock Direct | 8/1/2024 | A · Award | +58.87K | — | — | 46.6% | 126.22K | 185.08K |
| Total | +60.23K | $13.56K | ||||||
Derivative Transactions0
No derivative transactions reported